New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
The announcement follows a record-setting $1.2 million accelerated LineaDNA order
Liraglutide is a drug-device combination formulation used in the treatment of chronic weight management
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
To support this launch, ImmunityBio has established a wholly owned subsidiary in Saudi Arabia
Under the deal, Quiver will receive an undisclosed advance payment and research support
BLA is based on a robust data package supporting similarity to Orencia (abatacept) IV for infusion through totality of evidence including pharmacokinetic (PK) data
The clinical program has benefited from extensive European Union support, including the IMI2 TRIC-TB and UNITE4TB projects, as well as funding from the EDCTP2 bEto-TB project
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
Subscribe To Our Newsletter & Stay Updated
